Scientists have devised a technique to sort out which heart cells can replicate and which cannot, a critical step toward treatments that may one day help the heart heal itself after injury.
The method, published in the journal Circulation Research, removes a significant roadblock to developing ways to regrow healthy cardiac muscle tissue, a feat not currently possible.
“This new technique solves a longstanding problem that for years has stymied our ability to develop regenerative treatments for the heart,” said Stefan Jovinge, M.D., Ph.D., the study’s senior author and director of the DeVos Cardiovascular Research Program at Van Andel Institute and Spectrum Health. “It’s a major step forward that we aim to translate into improved patient care.”
For decades, scientists have searched for ways to harness the heart’s regenerative potential to fix damage related to heart attack and heart failure, but their attempts have been largely unsuccessful.
Unlike the skin or bones, which readily heal by stitching together wounds or breaks with new, healthy cells, heart muscle cells largely lose their ability to replicate early in life (instead, they progress through the cell cycle but, in most cases, they do not actually divide). This leaves patients and physicians with only a few surgical options to mitigate further damage and just one option to totally repair the problem should the damage be too severe: a heart transplant.
The new method combines two technologies — molecular beacon technology and fluorescence activated cell-sorting — to specifically isolate cells that successfully divide. This will allow scientists to determine the mechanisms underlying heart muscle cells’ regenerative potential, which is critical to the development of regenerative strategies aimed to cure patients with heart injury.
“Now that we can accurately identify these cells, we can start to determine the mechanisms that allow them to divide and develop ways to jump-start this process,” Jovinge said. “This work is an excellent example of how basic research can have a major impact on future clinical care.”
The findings build on previous research by Jovinge’s team that showed, contrary to long-held beliefs, some cells in the heart are indeed capable of replicating. This discovery was hailed as a “notable advance of 2015” by Nature Medicine, one of the world’s top medical research journals.
The Latest on: Regenerative cardiac therapies
via Google News
The Latest on: Regenerative cardiac therapies
- Gut microbiome as a tool in regenerative medicine; Novel approach driven by GN Corp Japan with potentials in neurological illnesseson May 6, 2022 at 8:31 pm
Further, a balanced GM is important to cardiac repair ... founded Nichi-In Centre for Regenerative Medicine and initiated stem cell research yielding cell therapy solutions in the specialties ...
- Gut microbiome as a tool in regenerative medicine; Novel approach driven by GN Corp Japan with potentials in neurological illnesseson May 6, 2022 at 7:22 pm
Regenerative medicine uses tools that include ... and immunosuppressive therapy disrupt the gut microbiome. Valid strategies that work to counter the side effects include lactobacillus ...
- Gut microbiome as a tool in regenerative medicine; Novel approach driven by GN Corp Japan with potentials in neurological illnesseson May 6, 2022 at 12:17 pm
However, there exists another tool involving the gut microbiome (GM) which plays a significant role in supporting all RM tools both directly and indirectly ( In Neurological diseases, one of the major ...
- FDA grants RMAT designation to obecabatagene autoleucel for acute lymphoblastic leukemiaon May 5, 2022 at 5:34 am
Back to Healio The FDA granted regenerative medicine advanced therapy designation to obecabatagene autoleucel for the treatment of adults with relapsed or refractory B-cell acute lymphoblastic ...
- Global, U.S. & Europe Regenerative Medicines Market Share Current And Future Industry Trends, 2022-2031on May 5, 2022 at 3:57 am
Kenneth Research, in its repository of market research reports, has recently added a report titled Global, U.S. & Europe Regenerative Medicines Ma ...
- Therapy Insight: Cardiovascular Complications Associated With Muscular Dystrophyon May 1, 2022 at 5:01 pm
These therapies are expected to also improve the cardiac function ...  In normal skeletal muscle, there is a robust regenerative response that leads to the formation of new myofibers, but ...
- Global Acellular Therapy Market - Strategies and Applications: Focus on Application, Pipeline, and Competitive Landscapeon April 20, 2022 at 6:05 pm
Cell-Free Therapy • Application of Extracellular Vesicles (EVs) in Regenerative Medicine • Acellular Therapy ... neurological disorders or cardiac diseases? • Which regulatory procedures are required ...
- Global Acellular Therapy Market - Strategies and...on April 20, 2022 at 7:46 am
neurological disorders or cardiac diseases? • Which regulatory procedures are required to unify the approval process for the emerging acellular therapy market? • What are the gaps in ...
- Global Acellular Therapy Market - Strategies and Applications: Focus on Application, Pipeline, and Competitive Landscapeon April 20, 2022 at 7:42 am
Cell-Free Therapy • Application of Extracellular Vesicles (EVs) in Regenerative Medicine ... neurological disorders or cardiac diseases? • Which regulatory procedures are required to ...
via Bing News